Viewing Study NCT06204315



Ignite Creation Date: 2024-05-06 @ 7:59 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Study NCT ID: NCT06204315
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-27
First Post: 2024-01-03

Brief Title: Risk Adapted Spinal CordCauda Constraint Relaxation for High-risk Patients With Metastatic Epidural Spinal Cord Compression Undergoing Spine Stereotactic Radiosurgery
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Study Overview

Official Title: Risk Adapted Spinal CordCauda Constraint Relaxation for High-risk Patients With Metastatic Epidural Spinal Cord Compression Undergoing Spine Stereotactic Radiosurgery
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To learn about the safety of a procedure called cord dose escalated spine stereotactic radiosurgery CDE-SSRS in patients with MESCC
Detailed Description: Primary Objectives The primary protocol objectives are to establish the safety of CDE-SSRS alone in participants with MESCC Specifically we aim to maintain an RM risk no greater than 1 RM will be defined as non-functional paresis per the McCormick score ie Grade D

Secondary Objectives Secondary objectives include pain control as measured by the Brief Pain Inventory quality of life as measured by the EQ-5D symptom burden as measured by the MDASI-SP overall survival toxicity ambulatory rate and cost-effectiveness LC will be defined radiographically with serial MRI scans by the study radiologist per SPINO criteria

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
NCI-2024-00049 OTHER NCI-CTRP Clinical Registry None